This experiment was conducted to determine whether dietary cholecalciferol will alleviate a calcium and phosphorous (CaeP) deficiency when one-alpha-hydroxy-cholecalciferol, 1a(OH)D 3 , is supplemented, and to determine the effects of adequate and inadequate CaeP when 1a(OH)D 3 is supplemented and vitamin D 3 is adequate. A total of 144 one-d-old broiler chicks (Ross 308) were allocated to 3 treatments. The dietary treatments were as follows: treatment A, adequate CaeP þ cholecalciferol þ 5 mg/kg 1a(OH)D 3 ; treatment B, inadequate CaeP þ cholecalciferol þ 5 mg/kg 1a(OH)D 3 ; treatment C, inadequate CaeP þ 5 mg/kg 1a(OH)D 3 . All diets were mixed with 500 FTU/kg of phytase, and cholecalciferol was provided in 5,000 IU/kg except for treatment C that fed diets without vitamin D 3. The CaeP levels in the adequate diets were 0.90% Ca, 0.66% total phosphorus (tP); 0.75% Ca, 0.59% tP; 0.69% Ca, 0.54% tP for the starter, grower and finisher periods. At d 42 of age, broilers were inspected for incidence and severity of tibial dyschondroplasia (TD). The results showed that inadequate CaeP supplementation with cholecalciferol significantly decreased the incidence of TD, score and tibia ash compared with broilers fed the same diet in the absence of cholecalciferol (P < 0.05). The broilers fed inadequate CaeP diets with cholecalciferol were unable to achieve the same tibia ash and incidence of TD as those fed CaeP adequate diets (P < 0.05).
Introduction
Avian tibial dyschondroplasia (TD), a disease commonly found in modern meat type birds such as broilers, is very sensitive to the vitamin D metabolism. The major perturbation leading to the TD is that the chondrocytes do not fully hypertrophy but rather accumulate along the growth plate of long bones such as the tibia (Farquharson and Jefferies, 2000) . These abnormal accumulations may extend to large opaque plugs that eventually contribute to bone abnormalities. In addition to the vitamin D status of the bird, the dietary CaeP level influences this insufficiency of chondrocyte maturation. Whitehead et al. (2004) reported that high dietary concentrations of vitamin D 3 could prevent TD. It has been previously shown that addition of vitamin D metabolites to the diet of broiler chickens reduced the incidence of TD (Roberson and Edwards, 1996; Elliot and Edwards, 1997; Mitchell et al., 1997a,b; Xu et al., 1997; McCormack et al., 2004; N€ a€ as et al., 2012; Atencio et al., 2005a) .
As an analog of vitamin D, one-alpha-hydroxy-cholecalciferol, 1a(OH)D 3 , has been demonstrated to improve growth performance, tibia quality and P utilization in broilers (Snow et al., 2004) . Edwards (2002) indicated that addition of 1a(OH)D 3 enhanced phytate phosphorus utilization in broilers, although the intestinal phytase activity of broilers was not influenced via 1a(OH)D 3 . Landy et al. (2015) reported that in CaeP deficiency diets and without vitamin D 3 , addition of 1a(OH)D 3 improved tibia ash, Ca and P of broilers. However, when vitamin D 3 was enough, tibia qualities of broilers was not improved by 1a(OH)D 3 addition.
This experiment was conducted to determine whether dietary cholecalciferol will alleviate a CaeP deficiency when 1a(OH)D 3 is supplemented, and to determine the effects of adequate and inadequate CaeP when 1a(OH)D 3 is supplemented and vitamin D 3 is adequate.
Materials and methods

Ethical matters
The broilers were purchased from a local hatchery and reared in accordance with the U.S. National Institutes of Health Guide for the Care and Use of Laboratory Animals. Furthermore, the handling of birds complied with the ethical guidelines of the Isfahan University's Ethical Committee (approval ref No. 2015-234) .
Animals and dietary treatments
One hundred forty-four 1-d-old broiler chicks (as-hatched) were randomly assigned to 3 dietary treatments for 6 wk. The broilers were fed starter diets from 1 to 10 d of age, grower diets from 11 to 24 d, and finisher diets from 25 to 42 d (Table 1) . The dietary were formulated by Amino-feed software to meet nutrient requirements of broilers (Ross 308, 2014) except for Ca, P and cholecalciferol. The dietary treatments were as follows: treatment A, adequate CaeP þ cholecalciferol þ 5 mg/kg 1a(OH)D 3 ; treatment B, inadequate CaeP þ cholecalciferol þ 5 mg/kg 1a(OH)D 3 ; treatment C, inadequate CaeP þ 5 mg/kg 1a(OH)D 3 . The CaeP levels in the adequate diets were 0.90% Ca, 0.66% total phosphorus (tP); 0.75% Ca, 0.59% tP; 0.69% Ca, 0.54% tP for the starter, grower and finisher periods. The Ca and P levels in the inadequate diets were 0.80% Ca, 0.61% tP; 0.65% Ca, 0.54% tP; 0.59% Ca, 0.49% tP for the starter, grower and finisher periods. All diets were mixed with 500 FTU/kg of Phyzyme XP 5000 phytase (Danisco Animal Nutrition) and 5 mg/kg of 1a(OH)D 3 (Vitamin Derivatives Inc., Georgia, USA), and cholecalciferol was provided in 5,000 IU/kg except for treatment C that fed diets without vitamin D 3. Each replicate was assigned to a clean floor pen (120 cm Â 120 cm Â 80 cm) for 6 wk, and feed and water were provided for ad libitum consumption throughout the entire experimental period. To prevent exposure to ultraviolet light, the windows in broiler house were covered with clear plastic, and incandescent bulbs provided lighting. Except for d 1, a period of 23 h light and 1 h of darkness lighting schedule was applied. The experimental house temperature was controlled at 32 C during the starter phase, 27 C during the grower phase and 22 C for the rest of the experiment.
Chemical analysis
At 42 d of age, 2 male broilers per pen were chosen, based on the average weight of the group, and sacrificed by cervical dislocation, and the right tibia was evaluated for TD as described by Edwards and Veltmann (1983) . The left tibia was removed from each bird for bone ash analysis on a dry fat-free basis (method 22.10; AOAC, 1995).
Statistical analysis
The data were subjected to analysis of variance procedures appropriate for a completely randomized design using the GLM procedures of SAS (SAS Institute Inc., Cary, NC) to estimate the significance of the treatment effects. Means were compared using the LSD method. Statements of probability are based on P < 0.05.
Results
Data on tibia quality are summarized in Table 2 . Treatments failed to induce any effect on tibia diameter, though it tended to 
Discussion
In the present study, 1a(OH)D 3 negatively influenced bone mineralization when dietary cholecalciferol was adequate. Edwards (2002) reported that addition of 1a(OH)D 3 in basal diets with tP of 7.0 g/kg and without cholecalciferol could improve performance of broilers. However when dietary cholecalciferol was adequate (Biehl et al., 1997) , performance of broilers was not improved by 1a(OH) D 3 supplementation. Considering the possibility of interaction between 1a(OH)D 3 and cholecalciferol, the effect of 1a(OH)D 3 alone or in combination with different levels of cholecalciferol should be investigated in broilers chickens.
In this trial feeding inadequate CaeP diets containing 1a(OH)D 3 in combination with cholecalciferol adversely affect bone development compared with broilers fed inadequate CaeP diets containing 1a(OH)D 3 in the absence of cholecalciferol. Landy et al. (2015) reported that CaeP deficiency diets and without vitamin D 3 , 1a(OH)D 3 improved tibia parameters of broilers. However, when vitamin D 3 was adequate, tibia qualities of broilers was not improved by 1a(OH)D 3 addition. Similarly, Atencio et al. (2005b) reported that a complement of 25(OH)D 3 enhanced the hen-day egg production in broiler breeders but only at very low levels of overall cholecalciferol addition. Consistently, Edwards (2002) found that an interaction between vitamin D 3 and 1,25(OH) 2 D 3 exists in tibia ash.
In this trial, feeding inadequate CaeP diets containing 1a(OH)D 3 in combination with cholecalciferol decreased incidence and severity of TD compared with broilers fed inadequate CaeP diets containing 1a(OH)D 3 in the absence of cholecalciferol. Elliot and Edwards (1992) reported high incidence of TD which was associated with elevated plasma l,25(OH) 2 D 3 . In contrast, Newbrey et al. (1988) found no correlation between the incidence of TD and plasma l,25(OH) 2 D 3 . Drewe et al. (1988) reported that both l,25(OH) 2 D 3 and 25(OH)D 3 were enhanced in plasma when 1,25(OH) 2 D 3 was supplemented to a diet that was inadequate in cholecalciferol. However, Rennie et al. (1993) reported no changes in plasma l,25(OH) 2 D 3 when l,25(OH) 2 D 3 was supplemented to a diet that was adequate in cholecalciferol. It seems that in the present study addition of cholecalciferol to the CaeP deficiency diet containing 1a(OH)D 3 could decrease l,25(OH) 2 D 3 plasma level due to interaction between cholecalciferol and 1a(OH)D 3 (Edwards, 2002) and thereby decreased incidence and severity of TD.
Conclusion
In conclusion, this trial suggests that broilers fed an inadequate CaeP diet with 1a(OH)D 3 and adequate level of cholecalciferol are unable to sufficient bone formation. There was no indication that 1a(OH)D 3 in the absence of cholecalciferol was effective in reducing TD whereas it could improve tibia ash. Considering the possibility of interaction between 1a(OH)D 3 and cholecalciferol, the effect of 1a(OH)D 3 alone or in combination with different levels of cholecalciferol should be investigated in broilers chickens.
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